Skip to main content

Table 5 Dosage Details as Recommended for Remission-Maintenance Immunosuppressive Therapy [42, 43, 56, 64]

From: Cerebral involvement in systemic vasculitides

AZA 2 mg/kg oral daily
MTX 20–25 mg oral or parenteral weekly
RTX 500 mg i.v. on day 0 and 14, then every 6 months
Leflunomid 20–30 mg oral daily
MMF 2 g oral daily
  1. Abbreviation: i.v. Intravenous
Back to article page

Neurological Research and Practice

ISSN: 2524-3489

Contact us